• O NAMA

Welcome

Forgot password?

Not a member? Join today

Logo
  • Početna
  • Bolesti
    • Hronična limfocitna leukemija
    • Non hočkinski limfom
    • Hočkinski limfom
    • Leukemije
      • AML
      • ALL
  • Edukacija
    • Prezentacije
      • HLL
      • NHL
      • HL
    • Kvizovi
      • HLL
      • NHL
      • HL
  • Stil života
    • Zdraviji recepti
    • Fizička aktivnost
    • Prevencija
    • Korisni saveti
  • Resursi
    • Video
    • Brošure
    • Infografike
  • Blog
  • English
  • Početna
  • Bolesti
    • Hronična limfocitna leukemija
    • Non hočkinski limfom
    • Hočkinski limfom
    • Leukemije
      • AML
      • ALL
  • Edukacija
    • Prezentacije
      • HLL
      • NHL
      • HL
    • Kvizovi
      • HLL
      • NHL
      • HL
  • Stil života
    • Zdraviji recepti
    • Fizička aktivnost
    • Prevencija
    • Korisni saveti
  • Resursi
    • Video
    • Brošure
    • Infografike
  • Blog
  • English
30 Aug 2017
  • maja
  • Uncategorized

Počelo istraživanje koje je dizajnirano da istraži potrebe pacijenata sa hroničnom limfocitnom leukemijom (HLL) u Evropi

Udruženje LIPA podržava istraživanje na prostoru cele Evrope koje je dizajnirano da istraži potrebe pacijenata sa hroničnom limfocitnom

Read More

30 Aug 2017
  • maja
  • Hočkinov limfom

Management and controversies of classical Hodgkin lymphoma in pregnancy

Management and controversies of classical Hodgkin lymphoma in pregnancy The goal of managing classical Hodgkin lymphoma (cHL) in pregnancy is to

Read More

30 Aug 2017
  • maja
  • Hočkinov limfom

Risk of central nervous system relapse in non-Hodgkin lymphoma patients treated with EPOCH-R

Risk of central nervous system relapse in non-Hodgkin lymphoma patients treated with EPOCH-R The authors looked at relapses that occur in the

Read More

13 Aug 2017
  • maja
  • Hronična limfocitna leukemija

The benefits of combining antibody treatment and chemotherapy for previously untreated CLL patients

The benefits of combining antibody treatment and chemotherapy for previously untreated CLL patients This study compared the effectiveness of

Read More

13 Aug 2017
  • maja
  • Hronična limfocitna leukemija

Comparing genetic abnormalities and outcomes of CLL and monoclonal B-Cell lymphocytosis

Comparing genetic abnormalities and outcomes of CLL and monoclonal B-Cell lymphocytosis This study examined genetic abnormalities monoclonal

Read More

  • 1
  • 2
  • 3
  • 4
  • 5

Pretraga

Najnoviji postovi

  • Evaluating the risk of developing acute myeloid leukemia or myelodysplastic syndrome after a stem cell transplant
  • Hodgkin Lymphoma Above and Below the Diaphragm: Are The Outcomes Different?
  • Chlorambucil, rituximab and lenalidomide combination treatment for patients with chronic lymphocytic leukemia
  • Evaluating the safety of ibrutinib in leukemia and lymphoma
  • Diffuse large B-cell lymphoma: 10 years’ real-world clinical experience with rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisolone

Arhiva

  • October 2018
  • April 2018
  • January 2018
  • December 2017
  • November 2017
  • October 2017
  • September 2017
  • August 2017

Kalendar

December 2025
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
293031  
« Oct    

Categories

  • Hočkinov limfom (3)
  • Hronična limfocitna leukemija (9)
  • Nehočkinski limfom (4)
  • Uncategorized (8)

Novosti

Follow Us

Izradu platforme podržala kompanija

KONTAKT

Udruženje LIPA
+ 381 60 0 222 317
majaklipa@gmail.com
www.lipa.org.rs

Budite u toku sa najnovijim dešavanjima. Prijavite se

© Copyright LIPA 2017